PANHANDLE NUCLEAR RX, LTD.

PANHANDLE NUCLEAR RX, LTD. specializes in the manufacturing and supply of radiopharmaceuticals for medical diagnostics and therapeutic applications, operating under NAICS 325412 for pharmaceutical preparation manufacturing. The company’s technical expertise centers on the production, formulation, and quality-controlled distribution of radioisotope-based agents used in nuclear medicine, including those employed in PET and SPECT imaging. Their work requires strict adherence to cGMP standards, radiological safety protocols, and precise half-life management to ensure efficacy and patient safety. A key differentiator is their consistent delivery of mission-critical radiopharmaceuticals to specialized healthcare facilities, demonstrating proficiency in cold chain logistics, sterile compounding, and regulatory compliance for radioactive materials. The contractor maintains a sustained, long-term relationship with the Department of Veterans Affairs, supplying radiopharmaceuticals to VA medical centers across the nation. Their work supports nuclear medicine departments in diagnosing cardiovascular, oncological, and neurological conditions among veteran populations, indicating deep familiarity with VA’s clinical workflows and procurement requirements for nuclear healthcare supplies. PANHANDLE NUCLEAR RX, LTD. is narrowly focused on the radiopharmaceutical manufacturing vertical within the broader pharmaceutical sector, positioning itself as a niche provider in the federal nuclear medicine supply chain. Their market presence is defined by precision, regulatory rigor, and reliability in delivering time-sensitive isotopic products. As a small business entity structured as 2K (Small Disadvantaged Business), the company operates from Amarillo, Texas, with no public certifications listed. Its geographic base supports regional distribution networks while serving national federal healthcare needs, particularly in radiological diagnostics for government-funded medical systems.